{"filings":[{"id":105043,"accession_number":"0001193125-26-028333","cik":1527599,"company_name":"SYNLOGIC, INC.","ticker":"SYBX","form_type":"8-K/A","filed_at":"2026-01-29T23:59:59+00:00","items":["8.01","3.01"],"status":"ready","headline":"Synlogic confirms Nasdaq delisting, will trade on OTCQB as public shell","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Withdrew Nasdaq hearing on Jan 16, 2026; shares suspended Jan 21, 2026.","Believes it is a 'public shell' under Nasdaq rules post-delisting.","Applied for OTCQB Venture Market quotation; expects trading to begin soon.","Remains an SEC reporting company; business operations unaffected by transition.","No financial or operational changes announced; forward-looking statements caution."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":7719783.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105044,"accession_number":"0001193125-26-016040","cik":1527599,"company_name":"SYNLOGIC, INC.","ticker":"SYBX","form_type":"8-K","filed_at":"2026-01-20T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Synlogic withdraws Nasdaq hearing; shares suspended Jan 21, will move to OTC Markets","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Synlogic withdrew its Nasdaq hearing request on Jan 16, 2026, after being deemed a public shell.","Nasdaq will suspend trading of SYBX common stock at open of business on January 21, 2026.","Company expects shares to be quoted on OTC Markets Group; remains an SEC reporting company.","Business operations expected unaffected by the delisting; no financial impact disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":7719783.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121289,"accession_number":"0001193125-25-319653","cik":1527599,"company_name":"SYNLOGIC, INC.","ticker":"SYBX","form_type":"8-K","filed_at":"2025-12-16T23:59:59+00:00","items":["5.02","5.07"],"status":"ready","headline":"Shareholders approve 2025 Equity Incentive Plan and reelect directors at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["2025 Plan approved: 1,000,000 new shares authorized, plus up to 332,468 from lapsing 2015 Plan awards.","Directors James Flynn and Richard P. Shea reelected as Class I directors with strong support.","Non-binding advisory vote on executive compensation approved (7.75M for, 17.5K against).","Ratification of KPMG as independent auditor for fiscal year 2025 (10.28M for)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":7719783.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121288,"accession_number":"0001193125-25-300824","cik":1527599,"company_name":"SYNLOGIC, INC.","ticker":"SYBX","form_type":"8-K","filed_at":"2025-11-26T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Nasdaq notifies Synlogic it is a public shell; delisting possible unless hearing succeeds","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq Staff believes Synlogic is a public shell, citing zero revenue, minimal R&D costs, and reduced operations since Feb 2024.","Notice received Nov 21, 2025; company disagrees and intends to request a hearing to contest the Staff's determination.","Hearing request automatically stays suspension/delisting pending outcome, but there is no assurance of a successful result.","Quarterly reports for nine months 2025 show no revenue and only $16,000 in R&D expenses, per the Staff."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":7719783.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173845,"accession_number":"0000950170-25-024891","cik":1527599,"company_name":"SYNLOGIC, INC.","ticker":"SYBX","form_type":"8-K","filed_at":"2025-02-21T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Synlogic Director Michael Heffernan Resigns from Board and Committees","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michael Heffernan resigned from the Synlogic board and its audit and nominating/governance committees on February 20, 2025.","The resignation was voluntary and not due to any disagreement with the company's operations, policies, or practices.","Heffernan's departure is effective immediately, reducing the board's committee membership.","Synlogic (SYBX) disclosed the change in a Form 8-K filed on February 21, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":7719783.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173844,"accession_number":"0000950170-25-005425","cik":1527599,"company_name":"SYNLOGIC, INC.","ticker":"SYBX","form_type":"8-K","filed_at":"2025-01-14T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Synlogic board member Nick Leschly resigns effective Jan 10, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Nick Leschly resigned from the Board and compensation committee on Jan 10, 2025.","Resignation was voluntary and not due to any disagreement with the company.","No replacement has been announced; board seat remains vacant."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":7719783.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190823,"accession_number":"0000950170-24-139249","cik":1527599,"company_name":"SYNLOGIC, INC.","ticker":"SYBX","form_type":"8-K","filed_at":"2024-12-23T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Synlogic CEO Antoine Awad leaves Dec 31; Mary Beth Dooley named new Principal Executive Officer and CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Antoine Awad's employment ends Dec 31, 2024; receives $218,856 lump-sum (6 months salary) plus $246,213 retention bonus.","Mary Beth Dooley, Head of Finance, appointed Principal Executive Officer and Principal Financial Officer effective Jan 1, 2025.","Dooley's base salary $325,000; 2024 target bonus 30% ($97,500); no bonus for 2025 or later.","Awad enters consulting agreement at $350/hour; equity grants extended and accelerated on change in control or dissolution."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":7719783.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190822,"accession_number":"0000950170-24-133381","cik":1527599,"company_name":"SYNLOGIC, INC.","ticker":"SYBX","form_type":"8-K","filed_at":"2024-12-05T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Synlogic stockholders reelect Nick Leschly as Class III director at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Nick Leschly reelected as Class III director with 6,876,144 votes for and 317,492 withheld.","Non-binding advisory vote on executive compensation approved: 3,337,618 for, 543,326 against, 3,312,692 abstentions.","Ratification of KPMG as auditor for FY2024: 9,589,958 for, 43,758 against.","Quorum of 9,633,925 shares (82.36% of outstanding) present at the meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":7719783.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190821,"accession_number":"0000950170-24-125523","cik":1527599,"company_name":"SYNLOGIC, INC.","ticker":"SYBX","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Synlogic posts Q3 net loss of $0.1M, cash $19.4M; evaluating strategic options","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Net loss of $0.1M ($0.01 per share) vs $12.1M ($2.57 loss per share) in Q3 2023.","Cash and cash equivalents of $19.4M as of Sep 30, 2024; no revenue for Q3.","R&D expenses show $0.7M benefit due to clinical trial refund and accrual reversal.","Restructuring charges of $0.3M related to workforce reduction from Synpheny-3 discontinuation.","Retained Lucid Capital Markets to explore strategic alternatives including M&A or business combination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":7719783.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207295,"accession_number":"0000950170-24-093291","cik":1527599,"company_name":"SYNLOGIC, INC.","ticker":"SYBX","form_type":"8-K","filed_at":"2024-08-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Synlogic reports Q2 net income $2M on restructuring gain; exploring strategic options","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Cash and equivalents $20.0M as of June 30, 2024.","Net income $2.0M ($0.16/share) vs net loss $15.0M ($3.21/share) in Q2 2023; revenue zero.","R&D expenses fell to $2.2M from $11.8M YoY; restructuring gain of $3.8M from lease termination.","Retained Lucid Capital Markets to evaluate strategic alternatives including acquisition or merger.","In Feb 2024, discontinued pivotal PKU study (Synpheny-3) and reduced workforce."],"consensus_eps_estimate":-0.5202,"consensus_eps_actual":-2.43,"consensus_revenue_estimate":null,"consensus_revenue_actual":8000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl+finnhub","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":7719783.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224705,"accession_number":"0000950170-24-059063","cik":1527599,"company_name":"SYNLOGIC, INC.","ticker":"SYBX","form_type":"8-K","filed_at":"2024-05-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Synlogic posts Q1 net loss of $31.6M; retains advisor to explore strategic alternatives","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Retained Lucid Capital Markets to evaluate acquisition, merger, or other strategic transaction.","Cash and short-term securities of $32.3M as of March 31, 2024.","Net loss of $31.6M ($2.60 per share) versus $15.6M ($3.39) in Q1 2023.","Restructuring charge of $28.2M related to discontinuation of Phase 3 PKU study of SYNB1934.","R&D expenses fell to $7.7M from $12.5M; G&A to $2.9M from $4.0M year-over-year."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":7719783.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243969,"accession_number":"0000950170-24-034854","cik":1527599,"company_name":"SYNLOGIC, INC.","ticker":"SYBX","form_type":"8-K","filed_at":"2024-03-21T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Synlogic appoints James Flynn to board; three directors resign same week","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["James Flynn appointed as Class I director effective March 19; he manages Nerium Capital, a healthcare-focused investment fund.","Flynn granted stock option for 4,000 shares and annual cash retainer of $40,000 (prorated).","Three directors resigned March 20: Mike Burgess, Lisa Kelly-Croswell, Patricia N. Hurter; none due to disagreement.","Resignations affect Audit, Compensation, Nominating & Governance, and Science & Technology committees."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":7719783.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243968,"accession_number":"0000950170-24-033145","cik":1527599,"company_name":"SYNLOGIC, INC.","ticker":"SYBX","form_type":"8-K","filed_at":"2024-03-19T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Synlogic discontinues PKU program; Q4 net loss $14.5M, cash $47.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Discontinued Synpheny-3 pivotal study of SYNB1934 for PKU; evaluating strategic options.","Q4 2023 revenue $2.8M (vs $0.1M prior year) from Roche collaboration.","Q4 net loss $14.5M ($1.71 per share) vs $16.7M ($3.54 per share) prior year.","Full year 2023 net loss $57.3M ($8.81 per share) vs $66.1M ($13.83) prior year.","Cash and equivalents $47.7M as of Dec 31, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":7719783.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}